Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

1. In a cross-over study a new low molecular weight heparinoid Org 10172 was administered to 12 elderly male and female volunteers. It was well tolerated and no adverse effects occurred. 2. The absolute bioavailability of Org 10172 as measured by plasma anti-Xa activity, glycosaminoglycuronans with...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Stiekema, J C, Wijnand, H P, Van Dinther, T G, Moelker, H C, Dawes, J, Vinchenzo, A, Toeberich, H
Médium: Artigo
Jazyk:Inglês
Vydáno: 1989
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379703/
https://ncbi.nlm.nih.gov/pubmed/2468354
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky